VisiVite® Launches AREDS2 E-Free Blue Formula: Macular Support for those on Anticoagulant Therapies
HUNTINGTON, N.Y., April 7, 2015 /PRNewswire/ -- Vitamin Science®, a world leader in eye vitamins, today announced its launch of AREDS2 E-Free Blue Formula for macular health. Designed for individuals who are taking warfarin (also known as Coumadin or Jantoven) and other anticoagulant therapies, as well as for anyone who may be avoiding high-dose vitamin E intake, AREDS2 E-Free Blue Formula reflects VisiVite's ongoing commitment to bringing effective, science-backed ocular nutrition to everyone.
Photo - http://photos.prnewswire.com/prnh/20150402/196247
Warfarin is a prescription blood-thinning drug that helps prevent the formation of blood clots. Taken by 20+ million adults, warfarin is the most widely prescribed anticoagulant of its kind. Though generally well-tolerated, warfarin is sometimes associated with abnormal bleeding – a potentially dangerous side effect that is exacerbated by vitamin E. This interaction creates an ocular nutrition challenge for people taking warfarin because the most evidence-backed macular health formulas – based on the National Eye Institute's AREDS and AREDS2 studies – both include vitamin E as a key antioxidant ingredient.
"Those taking warfarin and other anticoagulants are typically older and elderly adults: The very same populations that often have macular health concerns," says Dr. Paul Krawitz, acclaimed ophthalmologist, Vitamin Science, Inc. C.E.O., and VisiVite product formulator. "Our AREDS2 E-Free Blue Formula enables those individuals on anticoagulant therapy to continue supporting their macular health with advanced antioxidant nutrition that has no side effects or interactions with their blood thinning medications."
VisiVite's AREDS2 E-Free Blue Formula makes several notable enhancements to the National Eye Institute's AREDS2 study formula, yielding a highly concentrated macular health supplement. To restore the antioxidant activity lost with the removal of vitamin E, AREDS2 E-Free Blue Formula is formulated with a powerful blend of natural antioxidants that includes the following:
- FloraGLO® Lutein (20 mg): A macular antioxidant sourced from marigold flowers
- OmniXan® Zeaxanthin (4.75 mg): Prized paprika-sourced broad-spectrum antioxidants
- Selenium (200 mcg) + Zinc (80 mg): Highly active antioxidant mineral nutrition
- Grapeseed Extract (20 mg): Standardized to supply 95% antioxidant proanthocyanidins
- Bilberry (50 mg): A blueberry relative, high in eye-supportive antioxidant anthocyanosides
- Alpha Lipoic Acid (20 mg): "Universal Antioxidant"; fat- and water-soluble activity
- L-Glutathione (10 mg): Potent, liver-synthesized antioxidant; regenerates vitamin C
"Since vitamin E is a strong antioxidant used in both AREDS studies, we've taken great care to create an effective vitamin E substitute," continues Krawitz. "This dynamic antioxidant complex found in AREDS2 E-Free Blue Formula includes compounds with known eye health benefits that are also free of anticoagulant drug interactions and are extremely well-tolerated – helping everyone to get the macular nutrition that helps maintain their eyesight for life."
VisiVite AREDS2 E-Free Blue Formula and other VisiVite products are sold at VisiVite.Com, Vision-Nutrition.Com, BestEyeVitamins.Com, Amazon.Com and participating nutritional supplement stores and doctor offices. Wholesale accounts with a business tax ID number are welcomed.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. This product is not intended to be a substitute or replacement for any drug, surgery or any other medical treatment. Seek the advice of a competent health care professional for your specific health concerns. Individual results may vary.
Vitamin Science, Inc.
755 Park Avenue Suite 100, Huntington, NY, 11743, United States
www.visivite.com
SOURCE Vitamin Science
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article